India's Zydus Lifesciences is set to acquire an 85.6% stake in France's Amplitude Surgical for nearly $280 million to expand ...

India's Zydus Lifesciences said on Tuesday it will acquire an 85.6% stake in France's Amplitude Surgical for 256.8 million ...

Ahmedabad: Two female doctors — a junior ... and the matter reached the state health department. Hospital authorities were summoned and questioned. "Some quarters see it as a power struggle ...

The company is introducing country’s first flu protection quadrivalent influenza virus vaccine as per WHO recommended composition, the Ahmedabad-based drug major said in a statement. Zydus’s ...

The vaccine, developed at Zydus's Vaccine Technology Centre in Ahmedabad, is cleared by the Central Drug Laboratory (CDL) and aims to address the... New Delhi, Feb 26 (PTI) Zydus Lifesciences on ...

Ahmedabad-based Zydus Lifesciences is set to launch the vaccine VaxiFlu-4 to combat a new strain of the influenza virus, as per the WHO-recommended composition of quadrivalent influenza virus ...

Medical experts project the addition of around 3,000 private hospital beds in Ahmedabad over the next 5 to ... and full-time specialists across various departments including gynaecology, neurology, ...

We prepare you well to excel on the American Board of Psychiatry and Neurology certification exam and help you ... Acute Stroke a world-class comprehensive cancer center a regional hospital serving ...

The hospital said it will continue to care for pediatric patients with emergent needs in its emergency department and will work with other hospitals in the region to ensure patients requiring ...

Shruti K Bhardwaj, Chief Clinical Nutritionist at Zydus Hospital, Ahmedabad, advises, “To reduce the risk of gallstones, avoid very low-calorie diets and prioritise a balanced diet with healthy fats.

It was imposed last month in response to high demand in the accident and emergency departments at the two ... on 7 January was caused by "increased hospital visits due to flu, viral infections ...

The product would be manufactured at the Group's manufacturing site at SEZ, Ahmedabad. As per IQVIA MAT July 2024 data, Enzalutamide tablets (40 mg and 80 mg) had annual sales of USD 1,417.2 million ...